OncBioMune Pharmaceuticals CEO, Dr. Jon Head, Updates Progress of their Prostate Cancer Vaccine
Everett Jolly Interviews Dr. Jon Head, CEO for OncBioMune Pharmaceuticals, Inc. (OBMP) and they discuss current progress of their Phase I/II trials of their Prostate Cancer vaccine.
We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.